| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 519.9 | 424.8 | 407.7 |
| Other income | 1.3 | 23.9 | 6.6 |
| Total income | 521.2 | 448.7 | 414.3 |
| Profit before exceptional items & tax | -22.5 | 1.3 | -4.1 |
| Exceptional items | 11.1 | 7.9 | 0.0 |
| Profit before tax | -32.3 | -5.3 | -3.2 |
| Net profit | -33.6 | 86.3 | -10.7 |
| Operating margin | -6.2% | -1.2% | -0.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +27.50% |
|---|---|
| Operating profit, year on year | -122.40% |
| Operating profit, quarter on quarter | -5.30% |
BSE results filing, NSE: CAMLINFINE. Figures extracted from the filing.
Camlin Fine Sciences Ltd: key numbers
- Share price
- ₹97.30
- Market cap
- ₹1,869 Cr
- Revenue (annual)
- ₹1,723 Cr
- Net profit (annual)
- ₹27.63 Cr
- P/E (TTM)
- 317.8×Sector 37.5×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Camlin Fine Sciences Ltd
All →Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences filed a Postal Ballot Notice seeking approval to appoint Mr. Atul Pradhan as Non-Executive Independent Director. E-voting runs September 17 to October 16, 2026.
Camlin Fine Sciences Management Change
Camlin Fine Sciences appointed Mr. Atul Pradhan as Additional Non-Executive Independent Director effective September 11, 2026. The appointment is subject to shareholder approval via postal ballot.
Camlin Fine Sciences Earnings Call Transcript: Key Takeaways
Camlin Fine Sciences reported Q1 FY27 revenue of INR 5,199 million, up 28% YoY, though EBITDA margins were pressured to 4% by high raw material and freight costs.
- Call
- Guides 25% growth
Camlin Fine Sciences Investor Presentation: Key Takeaways
Camlin Fine Sciences reported record quarterly revenue of Rs 5,199 Mn for Q1FY27, up 27.5% YoY, driven by strong growth in Specialty Ingredients and Aroma segments.
Camlin Fine Sciences Earnings Call: Key Takeaways
Camlin Fine Sciences reported Q4 revenue of ₹424cr and FY26 revenue of ₹1,723cr. Strategy focuses on shifting from 'Straights' to 'Blends' and scaling Vanillin production.
Camlin Fine Sciences Earnings Call: Key Takeaways
CFS reported FY26 revenue of ₹17,233 mn (6% YoY growth) with an EBITDA margin of 6.2%. The company is pivoting towards high-value Blends and acquired Vinpai to diversify into natural ingredients.